Valeo Financial Advisors, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 159 filers reported holding HERON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.

Quarter-by-quarter ownership
Valeo Financial Advisors, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$3,000
-25.0%
2000.0%0.00%
Q4 2020$4,000
+33.3%
2000.0%0.00%
Q3 2020$3,000
-25.0%
200
-25.4%
0.00%
Q2 2020$4,0000.0%2680.0%0.00%
Q1 2020$4,000
-33.3%
2680.0%0.00%
-100.0%
Q4 2019$6,000
-33.3%
268
-42.7%
0.00%0.0%
Q3 2019$9,000
+12.5%
468
+4.0%
0.00%0.0%
Q2 2019$8,000
-27.3%
450
+1.1%
0.00%0.0%
Q1 2019$11,000
+120.0%
445
+122.5%
0.00%0.0%
Q4 2018$5,000
-16.7%
200
-3.4%
0.00%0.0%
Q3 2018$6,000
-25.0%
207
+3.5%
0.00%0.0%
Q2 2018$8,000
+33.3%
2000.0%0.00%0.0%
Q1 2018$6,000
+50.0%
2000.0%0.00%0.0%
Q4 2017$4,000
+33.3%
2000.0%0.00%0.0%
Q3 2017$3,0002000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders